American Cancer Society BrightEdge Annual Report Reveals Impact of $43 Million Deployed to Advance Innovation and Healthcare Access
October 28, 2024
October 28, 2024
ATLANTA, Georgia, Oct. 28 [Category: Medical] -- The American Cancer Society issued the following news release:
BOSTON, Oct. 28, 2024 BrightEdge LLC, the American Cancer Society's (ACS) venture capital and impact investment arm, has published its most recent annual report highlighting progress in the fight to end cancer as we know it. Since inception through EOY 2023, BrightEdge has invested a total of $43 million in 21 companies focused on developing innovations to address critical . . .
BOSTON, Oct. 28, 2024 BrightEdge LLC, the American Cancer Society's (ACS) venture capital and impact investment arm, has published its most recent annual report highlighting progress in the fight to end cancer as we know it. Since inception through EOY 2023, BrightEdge has invested a total of $43 million in 21 companies focused on developing innovations to address critical . . .